How the pharma industry is harnessing cryo-electron microscopy in drug discovery
Learn how AstraZeneca is adopting nascent cryo-electron microscopy (cryo-EM) technology to expand its targets for drug discovery
Learn how AstraZeneca is adopting nascent cryo-electron microscopy (cryo-EM) technology to expand its targets for drug discovery
Designed for use in decentralized, CLIA-waived settings, the test has been analytically verified in a study to deliver results comparable to standard laboratory methods
Experts share insights on protein complexity — offering tools and breakthrough discoveries that empower researchers to overcome obstacles in academia and industry
Therapeutic Oligonucleotides 2025: Drugging the Undruggable takes place at AstraZeneca in Gothenburg, Sweden from May 14–15
The Opera Phenix ® Plus High-Content Screening System is the premier confocal solution for today' most demanding high content applications. Drawing on over a decade of experience with the industry-leading Opera ® and Opera ® Phenix system, the Opera Phenix Plus is designed for high-throughput high-content assays, phenotypic screening, assays using complex disease models, such as live cells, primary cells and microtissues,…

Quiet. Fast. Accurate. Better sample labeling and tracking empowers better patient care.
Virologist Dr. Ryan McNamara discusses viral hijacking of extracellular vesicles and its potential for informing novel biotherapeutics
Discover the latest advances in food quality testing and authenticity determination
Discover the game-changing advancements and key discussions driving lab automation forward
The Mag-Bind cfDNA LSP Kit was showcased at SLAS2025 International Conference & Exhibition in San Diego, California
STRmix is sophisticated forensic software used to resolve mixed DNA profiles previously considered too complex to interpret.
A scalable, high-throughput, high-content screening solution with 7-channel high-intensity laser light source and machine learning capabilities

Waters and Wyatt Technology join forces to help accelerate the therapeutic pipeline and allow biotherapeutics to reach patients quicker
As the FDA and NIH plan to phase out animal-based drug testing, organ-chip models are filling this critical gap
Watch this on-demand webinar to learn more about new updates of the NanoDrop One platform
Learn how Solventum’s scalable chromatographic clarification platform is helping to meet the growing demands of modern bioprocessing